Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 395011Generated: November 3, 2026

Potassium Iodide → Methyl 4-[3-(3-chloro-6-methoxyquinolin-4-yl)-3-(r,s)-hydroxypropyl]-1-[2-(2,5-difluorophenylthio)ethyl]piperidine-4-carboxylate

https://huagongshe.com/reaction/395011

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium IodideHCID 4875—
ReactantPotassium CarbonateHCID 11430—
Reactant2-(2-bromoethylsulfanyl)-1,4-difluorobenzeneHCID 11521669—
ReactantEthyl 4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]piperidine-4-carboxylate dihydrochlorideHCID 22468601—
SolventWaterHCID 962—
SolventDiethyl EtherHCID 3283—
SolventDimethylformamideHCID 6228—
SolventAcetonitrileHCID 6342—
ProductMethyl 4-[3-(3-chloro-6-methoxyquinolin-4-yl)-3-(r,s)-hydroxypropyl]-1-[2-(2,5-difluorophenylthio)ethyl]piperidine-4-carboxylateHCID 2246978628.3%

Reaction Conditions

Temperature85 °C

Reaction Steps

A mixture of 1.75 g of ethyl 4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]piperidine-4-carboxylate dihydrochloride, 0.95 g of 2-(2-bromoethylthio)-1,4-difluorobenzene, 0.622 g of potassium iodide and 3.11 g of potassium carbonate in 30 cm3 of acetonitrile and 20 cm3 of dimethylformamide was heated with stirring for 18 hours at a temperature in the region of 85° C. After cooling to about 20° C., the reaction mixture was filtered through Celite and the filtrate was then concentrated to dryness under reduced pressure (2 kPa) at a temperature in the region of 40° C. The residue obtained was taken up in water and diethyl ether. The organic phase was dried over magnesium sulfate, filtered and then concentrated to dryness as above. The residue obtained was purified by chromatography under atmospheric pressure, on a column of silica gel (particle size 70-200μ; diameter 4 cm), eluting with a dichloromethane/methanol mixture (97.5/2.5 by volume). The fractions containing the product were combined and then concentrated to dryness according to the same conditions as above. 0.6 g of methyl 4-[3-(3-chloro-6-methoxyquinolin-4-yl)-3-(R,S)-hydroxypropyl]-1-[2-(2,5-difluorophenylthio)ethyl]piperidine-4-carboxylate was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06603005B2
Source datasetuspto-grants-2003_08
ORD IDord-e0d5f3f740de440c82b20595100bbd6e
Source noteuspto-grants-2003_08